Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Non-Hodgkin's”

1,760 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,760 results

Early research (Phase 1)Study completedNCT00569985
What this trial is testing

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 5
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Testing effectiveness (Phase 2)Ended earlyNCT02953509
What this trial is testing

Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Gilead Sciences 178
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Testing effectiveness (Phase 2)Looking for participantsNCT04669171
What this trial is testing

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone Lymphoma
Enterome 80
Early research (Phase 1)Ended earlyNCT03198234
What this trial is testing

Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders

Who this might be right for
AML - Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Mixed Phenotype Acute Leukemia+3 more
Roncarolo, Maria Grazia, MD 5
Testing effectiveness (Phase 2)Study completedNCT00004171
What this trial is testing

Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Not applicableLooking for participantsNCT02872987
What this trial is testing

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemiaNon-Hodgkin's Lymphoma
Goethe University 10,000
Early research (Phase 1)Study completedNCT01362452
What this trial is testing

Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00481871
What this trial is testing

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Who this might be right for
Relapsed or Refractory Lymphoproliferative MalignanciesHodgkin's LymphomaPeripheral T-cell Lymphoma+2 more
Acrotech Biopharma Inc. 119
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Testing effectiveness (Phase 2)Study completedNCT00547534
What this trial is testing

Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
University of Rochester 31
Testing effectiveness (Phase 2)Ended earlyNCT05144009
What this trial is testing

Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
ADC Therapeutics S.A. 41
Testing effectiveness (Phase 2)Ended earlyNCT00003498
What this trial is testing

Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Burzynski Research Institute 5
Testing effectiveness (Phase 2)Study completedNCT00381940
What this trial is testing

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+17 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Study completedNCT00143871
What this trial is testing

Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin's
University of Michigan Rogel Cancer Center 35
Post-approval studies (Phase 4)UnknownNCT04134247
What this trial is testing

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

Who this might be right for
Relapsed/Refractory Non-Hodgkin's Lymphoma
Shandong Provincial Hospital 120
Early research (Phase 1)Ended earlyNCT00521638
What this trial is testing

Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, B-Cell
Wyeth is now a wholly owned subsidiary of Pfizer 120
Testing effectiveness (Phase 2)Ended earlyNCT00788606
What this trial is testing

R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaB-cell Lymphoma
Royal Marsden NHS Foundation Trust 7
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Load More Results